Pictet Asset Management (Switzerland)’s Quest Diagnostics DGX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$137M	Sell	976,298 -88,240	-8%	-$12.2M	0.16%	162
2023 Q1	$151M	Sell	1,064,538 -53,775	-5%	-$7.69M	0.19%	150
2022 Q4	$175M	Sell	1,118,313 -22,811	-2%	-$3.28M	0.25%	122
2022 Q3	$140M	Sell	1,141,124 -91,378	-7%	-$12M	0.21%	149
2022 Q2	$164M	Sell	1,232,502 -14,173	-1%	-$1.93M	0.23%	136
2022 Q1	$171M	Sell	1,246,675 -42,786	-3%	-$5.96M	0.19%	155
2021 Q4	$223M	Sell	1,289,461 -2,679	-0.2%	-$408K	0.22%	136
2021 Q3	$188M	Buy	+1,292,140	New	+$189M	0.21%	142

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s DGX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Quest Diagnostics (DGX) stake by 8.3% in Q2 2023, selling an estimated $12.2M and leaving 976,298 shares worth $137M. The position accounts for 0.16% of the portfolio, ranked #162.

Pictet Asset Management (Switzerland) first reported a position in DGX in Q3 2021 and has held it in 8 quarters since. The position peaked at $223M in Q4 2021. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

Pictet Asset Management (Switzerland) held 976,298 shares of Quest Diagnostics worth $137M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 88,240 Quest Diagnostics shares in Q2 2023, an estimated $12.2M.
Quest Diagnostics made up 0.16% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #162 holding.
Pictet Asset Management (Switzerland) first reported a position in Quest Diagnostics in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Quest Diagnostics position peaked at $223M in Q4 2021.
820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.